Areas of discussion include Biology of HSV Infection - Organism Characteristics, Epidemiological Information (HSV-1, and HSV-2), Pathogenesis (Modes of Transmission and Disease Progression), Diagnosis, Treatment Options, and Prevention Approaches.

Speaker: Denise Heaney, Ph.D., Roche Diagnostics

Areas of discussion include Epidemiology (Natural History; Mode of Transmission; Worldwide prevalence of HIV), Virology of HIV (Characteristics of HIV; HIV progression in clinical settings), Detection of HIV Infection (Rapid detection (screening); NAT (Molecular confirmation)), and Management of an HIV infection (Viral Load monitoring determines the clinical course of action).

Speaker: Art Braden, Ph.D., Roche Diagnostics

Areas of discussion include Epidemiology (Natural History; Mode of Transmission and Types of Infections), Virology of CMV (Characteristics of Cytomegalovirus (CMV), Replication and Viral Infection, and Disease syndromes), Molecular Detection of an CMV (Signal Amplification; Target Amplification), Management of CMV Disease, and The Future of CMV Molecular testing.

Speaker: Art Braden, Ph.D., Roche Diagnostics

Speedier results and greater sensitivity of molecular screening can better detect MRSA and prevent the spread of infection, with a good balance between infection control and treatment costs.

We asked infection control professionals what they wanted in a molecular screening test for MRSA. They said make it simple, flexible and reliable

Professionals concerned about hospital infection control have innumerable questions about the need and efficacy of MRSA screening

Overview of the ATHENA cervical cancer screening clinical trial, a 47,000 patient US registration study, by Dr. Warner Huh (gynecological oncologist). This presentation includes a review of the data for both normal and ASC-US cytology. It also reviews new evidence supporting genotype assessment for the risk for cervical cancer.